Novel hypervariable erythrocyte surface expressed recombinant proteins show promise as serological markers of exposure to Plasmodium falciparum infection (2023)
Attributed to:
Adjunctive Ivermectin Mass Drug Administration for Malaria Elimination: A cluster randomized trial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.10.31.564916
Publication URI: http://dx.doi.org/10.1101/2023.10.31.564916
Type: Preprint